INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Engage with PAOs]( "How Pharmaceutical Companies Can Effectively Engage With PAOs")
How Pharmaceutical Companies Can Effectively Engage With PAOsExperts explain the role of Patient Advocacy Organizations (PAOs), tips for pharmaceutical companies and PAOs to forge strong relationships, and techniques to integrate patient perspectives.
-
![citeline and applied Bio bucket image]( "Full Patient Journey Data A Must For Clinical Planning")
Full Patient Journey Data A Must For Clinical PlanningMove beyond fragmented trial planning by using longitudinal patient insights to optimize protocols, improve site selection, and overcome recruitment hurdles for more predictable outcomes.
-
![GettyImages-576919878-analytics-computer-testing-research-data]( "EDC Powers End-To-End Data Management In Pharma-Sponsored Trials")
EDC Powers End-To-End Data Management In Pharma-Sponsored TrialsAs clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.
-
![GettyImages-1296723604 CRO turnover training]( "Key Risk Areas that Can Derail Clinical Trials with Ocular Endpoints")
Key Risk Areas that Can Derail Clinical Trials with Ocular EndpointsBy embracing point-of-need models and strategic collaborations, sponsors and CROs can streamline ophthalmic trials and maximize ROI while advancing sight-saving therapies.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
-
What Clinical Trial Decision Makers Are Prioritizing In 20255/7/2025
In 2025, clinical trial operations are undergoing a transformative shift driven by the need for speed, cost-efficiency, and patient-centered approaches.
-
What Your Payment Structure Says About Your Trial7/13/2026
Payment models influence trial efficiency, cost control, and site satisfaction. Choosing between visit-based simplicity and procedure-based precision can significantly impact budget accuracy, data timeliness, and overall study performance.
-
Do You Know Today, What Your Trial Will Spend Tomorrow?7/13/2026
Fragmented data and outdated forecasting can derail trial budgets. Real-time financial and operational insights improve accuracy and spending control.
-
Sleep Assessment In Sleep Disorders3/16/2026
Discover how continuous, objective monitoring in a home environment captures sleep improvements that traditional lab-based snapshots often miss, ensuring more accurate clinical outcomes.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1135140461-lab-team]( "Accelerate Approval Of Novel Therapies")
Learn how to make critical, data-driven decisions throughout the product development lifecycle and increase new therapies' probability of success.
-
![meeting]( "Get It Right The First Time: Strategic Clinical Development")
Start early and get it right the first time. Course correct with a changing landscape. Overcome obstacles within clinical development. Collaborate with the best strategists and problem-solvers in clinical development.
-
![patient recruitment iStock-1299220556]( "Introducing Citeline PatientMatch: Precision Patient Recruitment")
The window for identifying the right patients to enroll in clinical trials is shrinking. With Citeline PatientMatch, sponsors can pinpoint eligible patients before a treatment plan is finalized.
-
![GettyImages-1695276785 lab, vial, research]( "Central Laboratory Services For Multi-Site Studies")
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
-
![Getty Images- 1404912459 oncology]( "Making The Impossible Possible In Oncology And Hematology Clinical Development")
When the complexities of designing and executing cancer trials in a highly competitive market can mean delays in delivering urgently needed treatments to patients, it pays to have a trusted partner by your side.
